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Myotonic dystrophy protein kinase (DMPK) is a Ser/Thr-type protein kinase with unknown function,
originally identified as the product of the gene that is mutated by triplet repeat expansion in patients with
myotonic dystrophy type 1 (DM1). Alternative splicing of DMPK transcripts results in multiple protein
isoforms carrying distinct C termini. Here, we demonstrate by expressing individual DMPKs in various cell
types, including C2C12 and DMPK
/ myoblast cells, that unique sequence arrangements in these tails control
the specificity of anchoring into intracellular membranes. Mouse DMPK A and C were found to associate
specifically with either the endoplasmic reticulum (ER) or the mitochondrial outer membrane, whereas the
corresponding human DMPK A and C proteins both localized to mitochondria. Expression of mouse and
human DMPK A—but not C—isoforms in mammalian cells caused clustering of ER or mitochondria. Mem-
brane association of DMPK isoforms was resistant to alkaline conditions, and mutagenesis analysis showed
that proper anchoring was differentially dependent on basic residues flanking putative transmembrane do-
mains, demonstrating that DMPK tails form unique tail anchors. This work identifies DMPK as the first
kinase in the class of tail-anchored proteins, with a possible role in organelle distribution and dynamics.
Myotonic dystrophy protein kinase (DMPK) was discovered
more than a decade ago as the product of the gene that is
altered by (CTG)n repeat expansion in patients with myotonic
dystrophy type 1 (DM1) (6, 13, 31). Study of DMPK has thus
far been aimed primarily at its normal physiological role, be-
cause the coding information of the DMPK gene remains un-
altered in DM1 patients and disease-causing effects of muta-
tion appear to act primarily at the RNA rather than at the
protein level (28, 40). Bioinformatic, biochemical, and cell
biological studies demonstrated that DMPK is an evolutionar-
ily new protein found only in skeletal, cardiac, and smooth
muscle and epithelial cells in mammals (reference 45 and our
unpublished data).
The protein is related to Rho-kinase type protein kinases
(14, 26) and belongs to the family of AGC-kinases, with myo-
tonic dystrophy kinase-related Cdc42-binding kinase
(MRCK/) (29) and human p160ROCK, rat ROK, Caeno-
rhabditis elegans LET-502, and murine citron Rho-interacting
kinase (54) as its closest homologues. These kinases modulate
the actin cytoskeleton by regulating myosin phosphatase activ-
ity or by directly phosphorylating the myosin regulatory light
chain, thereby affecting stress fiber formation, smooth muscle
contraction, and cytokinesis (2, 11, 39).
Recent findings revealed that DMPK may participate in a
variety of cellular processes. As potential substrates for
DMPK, phospholemman (34), the -subunit of DHPR (51),
MKBP (49), CUGBP/hNab50 (41), and the myosin phospha-
tase targeting subunit 1 (MYPT1) (35, 54) have been identi-
fied. The latter finding could point to a role for DMPK in
cytoskeletal movement or intracellular transport dynamics,
similar to the function of ROCK/Rho-kinase/ROK and MRCK
in reorganization of the actin-based cytoskeleton, as effectors
of RhoA and Cdc42, respectively. However, the precise site(s)
of action and the relationship between DMPK expression and
regulation of myosin phosphatase activity via MYPT phos-
phorylation (35) remain to be established.
By prediction from gene structure data and by direct mRNA
expression studies, it was shown, by us and others, that multiple
DMPK isoforms arise in both humans and mice by alternative
splicing (15, 20, 52). DMPK isoforms have a leucine-rich N
terminus, a serine/threonine-type protein kinase domain, and a
coiled-coil region in common but vary in the presence or ab-
sence of a VSGGG amino acid sequence and in the nature of
the C terminus. Recently, the VSGGG motif was found to be
involved in mDMPK autophosphorylation and to be a deter-
minant of in-gel migration behavior and perhaps folding con-
figuration (54). The nature of the C terminus depends on the
mode of splicing, leading to expression of DMPK isoforms with
long tails predominant in the heart, skeletal muscle, and brain
and DMPKs with a 2-amino-acid tail in smooth muscle (15, 20)
(Fig. 1).
Previous studies have localized hDMPK to the neuromus-
cular junction in skeletal muscle and intercalated disks in car-
diac muscle (30, 38). However, in this work, mixtures of coex-
pressed instead of individual DMPK isoforms were studied,
because antibodies were used that recognize epitopes shared
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between the different coexpressed DMPK isoforms and with
other members of the family of Rho kinases (26).
With the ultimate goal of understanding the biological func-
tion of DMPK, we focused in this study on a comparison
between the subcellular localization of individual DMPK iso-
forms of mice and humans. We report that different DMPK
splice forms either are associated with the endoplasmic retic-
ulum (ER) or mitochondria or are cytosolic and that ortholo-
gous splice isoforms of humans and mice do not behave simi-
larly. Use of confocal laser scanning microscopy and
immunoelectron microscopy (immuno EM) in combination
with transient transfection and mutation analysis of individual
DMPK cDNAs in various cell types revealed new information
on the sequence and structure of targeting signals required for
localization to the mitochondrial outer membrane (MOM) or
the ER. Furthermore, we report that anchoring of human
DMPK A into the MOM affects mitochondrial distribution
whereas mouse DMPK A clusters the ER. Based on our ob-
servations, we classify DMPK as the first kinase member of a
special class of membrane proteins, termed tail-anchored (TA)
proteins. DMPK binding to membranes, with a specificity that
is divergent between mice and humans, could be a mechanism
for regulation of organellar fusion and transport and mito-
chondrial physiology.
MATERIALS AND METHODS
Cell culture and DNA transfection. COS-1 cells were cultured and transfected
using the DEAE-dextran procedure as described previously (15). Neuro-2A
(N2A), NIH 3T3, HeLa, and C2C12 cells were grown to subconfluence in Dul-
becco minimal essential medium supplemented with 10% fetal calf serum and
maintained at 37°C under a 5% CO2 atmosphere. N2A, NIH 3T3, HeLa, and
C2C12 cells were transiently transfected with various expression plasmids by using
Lipofectamine (Invitrogen) as specified by the manufacturer and maintained in
culture for an additional 24 h prior to analysis. Alternatively, we used adenovirus
vector-based DNA transduction for expression of single mDMPK isoforms in
immortalized DMPK/ myoblasts, which were grown at 33°C on Matrigel (BD
Biosciences)-coated dishes in Dulbecco minimal essential medium supplemented
with 20% fetal calf serum, 60 g of gentamicin per ml, and 10 U of gamma
interferon per ml. This myogenic cell line was derived from DMPK/ knockout
mice harboring the H-2Kb-tsA58 allele as described previously (33).
Plasmid and adenovirus vectors for DMPK expression and site-directed mu-
tagenesis. HA-tagged mDMPK A, C, and E cDNAs were generated in
pSG8Eco expression vectors (15). Various pEYFP/CFP-DMPK expression vec-
tors and mutation and deletion constructs were obtained by cloning the appro-
priate PCR fragments into restriction sites of pEYFP-C1 or pECFP-C1 (Clon-
tech) (see online supplemental information for details). All expression plasmids
contained the proper mouse or human DMPK 3 untranslated region. The
sequences of all fragments obtained by PCR were verified by DNA sequencing.
The ER was visualized using plasmid vector pEGFP-ER, which encodes en-
hanced green fluorescent protein (EGFP) with a calreticulin-derived ER target-
ing signal at its N terminus and a KDEL ER retention signal at its C terminus
(Clontech). To mark mitochondria for live-cell imaging (see below), cells were
labeled with a mitochondrial selective probe, Rhodamine 123 (Molecular
Probes), at a final concentration of 10 g/ml. The Golgi was visualized by
transfection of plasmid pEGFP-Golgi, which encodes an EGFP C-terminally
fused to the cytoplasmic, transmembrane, and stalk regions of human N-acetyl-
glucosaminyl transferase I, a known Golgi marker protein (47). E1/E3-deleted
serotype 5 adenovirus vectors encoding yellow fluorescent protein (YFP)-
mDMPK isoforms A, C, or E under the control of a cytomegalovirus immediate-
early promoter were generated using the AdEasy Vector System (17) as de-
scribed previously (9).
Immunofluorescence microscopy. For immunofluorescence microscopy, cells
were grown and transfected on glass coverslips. The cells were fixed in phos-
phate-buffered saline containing 2% formaldehyde 24 h after transfection and
permeabilized in phosphate-buffered saline containing 0.2% NP-40. Samples
were processed for immunofluorescence microscopy using standard procedures.
A rabbit anti-cytochrome c oxidase antibody was used to visualize mitochondria.
Mouse monoclonal antibody (mAb) 12CA5 was used to detect the HA epitope
tag, and mAb 414 was used as a nuclear envelope (NE) marker (57). Images of
fixed cells were obtained with a Bio-Rad MRC1024 confocal laser-scanning
microscope equipped with an argon/krypton laser, using a 60	 1.4 NA oil
objective and LaserSharp2000 acquisition software. Images were further pro-
cessed with Adobe Photoshop 7.0.
Live-cell imaging. N2A cells were grown and transfected with pEYFP-
mDMPK A or pECFP-mDMPK C together with pEGFP-ER or were labeled
with Rhodamine 123 in 35-mm glass-bottom dishes (Willco Wells BV). They
were washed twice in OptiMEM-I (Life Technologies), and live cells were im-
aged while placed on a temperature-controlled stage of a Zeiss LSM510-Meta
confocal microscope (running software release 3.2) using the appropriate argon
laser lines and a 63	 1.4 NA oil objective. In the case of overlapping GFP and
cyan fluorescent protein signals, the metadetector in conjunction with the linear
unmixing option in the software was used to generate the final images.
Immuno-EM. N2A cells were grown and transfected with plasmids YFP-
mDMPK A, C or E. They were fixed for 2 h at room temperature in 100 mM
sodium phosphate buffer (pH 7.0) containing 1% formaldehyde and 0.1% glu-
taraldehyde. Next, they were pelleted in 10% gelatin and postfixed in 1% form-
aldehyde for another 24 h. Ultrathin cryosections were prepared on a Leica
EMFCS, incubated with polyclonal antiserum raised against EGFP, and then
incubated with protein A complexed to 10-nm-diameter gold particles by stan-
dard procedures (12). Sections were observed in a JEOL 1010 electron micro-
scope operating at 80 kV.
SDS-PAGE and Western blotting. Transfected COS-1 cells were lysed in
RIPA buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 1 mM
phenylmethylsulfonyl fluoride, 10 mM NaF) and centrifuged for 10 min at 14,000
	 g. Cell lysates were analyzed by SDS-polyacrylamide gel electrophoresis
FIG. 1. Mouse DMPK splice isoforms have distinct C termini. The domain organization and C-terminal amino acid sequences of mDMPK
splice isoforms A, C, and E are shown. The N terminus, catalytic kinase domain, VSGGG segment, coiled-coil domain, and tail segments are
indicated. Amino acids common to all mDMPK isoforms are shown in bold, and residues identical in tail 1 and tail 2 are underlined.
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(PAGE) (8 or 12% polyacrylamide) and transferred to nitrocellulose membranes
(Amersham Pharmacia Biotech) for immunodetection using B79, a DMPK-
specific antibody (15), or anti-EGFP, followed by horseradish peroxidase-conju-
gated secondary antibodies (Jackson ImmunoResearch Laboratories). Immuno-
detection was performed by enhanced chemiluminescence and exposure to film
(Kodak X-OMAT AR).
Membrane isolation and extraction. N2A cells were grown in 100-mm-diam-
eter culture dishes and transfected with pSG8Eco-mDMPK expression plas-
mids. They were scraped into ice-cold 10% TES buffer (20 mM Tris-HCl [pH
7.5], 1 mM EDTA, 100 mM NaCl) plus 1 mM phenylmethylsulfonyl fluoride and
a protease inhibitor cocktail (Roche), pelleted by centrifugation for 10 min at
3,000 	 g, resuspended in 10% TES buffer, and incubated on ice for 15 min. Cell
lysates were made using a glass-glass Dounce homogenizer and were cleared
from intact cells and nuclei by centrifugation for 10 min at 3,000 	 g. An input
sample was collected from this supernatant for analysis by SDS-PAGE. Total
membranes were collected using a micro-ultracentrifuge (Sorvall RC M150 GX)
at 100,000 	 g for 30 min in a S55S rotor, and the supernatant fraction was
collected (designated S1) for SDS-PAGE analysis. Membranes obtained were
extracted on ice in (i) PBS, (ii) 1 M NaCl in PBS, (iii) 100 mM Na2CO3 (pH 11),
or (iv) 1% Triton X-100 in PBS and centrifuged for 30 min at 100,000 	 g.
Subsequent pellet (P) and supernatant (S2) fractions were analyzed by SDS-
PAGE followed by Western blotting using B79.
Supplemental material. Supplemental material is available online. Informa-
tion includes supplemental Materials and Methods, legends to supplemental
figures, and expression characterization of DMPK mutants used in this work
(Fig. S1), NE immunolocalization of YFP-mDMPK A mutants (Fig. S2), real-
time analysis of YFP-mDMPK A associated with the ER (movies Fig. S3A and
S3B), real-time analysis of CFP-mDMPK C associated with mitochondria (movie
Fig. S4), comparative analysis of mouse and human DMPK C-termini (Fig. S5;
Table S1), and expression of hDMPK A and C in C2C12 cells (Fig. S6).
RESULTS
The DMPK gene specifies different gene products. DMPK
splice forms A and C carry distinct C termini, here referred to
as tail 1 and tail 2, respectively, which are 96 and 95 amino
acids in length and are identical only in the N-terminal 16
amino acids (encoded by exon 13) (Fig. 1) (for details, see
reference 15). The short isoform DMPK E is distinctly differ-
ent and carries a short, truncated tail of 2 amino acids (desig-
nated tail 3). We previously reported that the splice modes
leading to this C-terminal variation have been conserved be-
tween mice and humans and we determined the subcellular
distribution of DMPK isoforms (54). Since this distribution
was originally studied in ectopic host cells and since neither the
conditions nor the exact mechanism for this targeted accumu-
lation are well understood, we decided to focus first on the
localization of individual splice products in authentic host cells.
C2C12 myoblasts and immortalized myoblasts derived from
DMPK/ knockout mice harboring the H-2Kb-tsA58 trans-
gene (33) were used for this purpose.
To analyze the specific distribution behavior of single iso-
forms, DMPKs were expressed as HA- or YFP-tagged versions
from plasmid or adenovirus vectors and their localization was
compared to that of various organellar markers by immuno-
fluorescence microscopy. As shown in Fig. 2A and B, reticular
structures revealed by staining of HA-tagged mDMPK A in
C2C12 cells overlapped with the ER network stained by tran-
sient expression of the GFP-ER marker, containing the calre-
ticulin ER targeting signal and KDEL ER retention signal.
Since mDMPK A was confined solely to ER contiguous mem-
branes (Fig. 2C), we tested colocalization with MAb414, a
nuclear envelope (NE) marker, directed against the nuclear
pore complex (57). Also, this marker colocalized (see Fig. S2A
to C in the supplemental material) showing that mDMPK A
decorates all membranes of the ER, since the NE is a subdo-
main of, and continuous with, the ER (53). The intensely
stained area observed close to the nucleus did not show any
appreciable colocalization with a GFP-Golgi marker contain-
ing the transmembrane and stalk region of human N-acetyl-
glucosaminyl transferase I (47), suggesting that tail 1 is specific
for ER and NE membranes and not for membranes in the
FIG. 2. Mouse DMPK A and C localize to the ER or mitochondria.
To assign subcellular DMPK location, confocal images were taken of
fluorescent products in C2C12 myoblast cells 24 h after cotransfection with
HA-tagged or YFP-tagged mDMPK isoforms A and C and various or-
ganellar markers. (A to C) HA-mDMPK A colocalized with a GFP-ER
marker containing the calreticulin ER-targeting signal and the KDEL ER
retention signal. The insert shows an enlargement of the peripheral ER
network. (D to F) Fluorescent visualization of cotransfected HA-
mDMPK A (D) and a GFP-Golgi (E) marker shows that mDMPK A is
not targeted to the Golgi. (G to I) YFP-mDMPK C localized to mito-
chondria, as shown by staining with an anti-cytochrome c oxidase anti-
body. (J) Strong overexpression of YFP-mDMPK C leads to a cytosolic
location in addition to perinuclear mitochondrial clustering. (K and L)
Localization of kinase-dead mutants YFP-mDMPK A(K100A) and
C(K100A) to the ER and mitochondria, respectively. (M and N) Adenovi-
rus gene transfer of YFP-mDMPK A and C into DMPK/ myoblasts
result in ER and mitochondrial localization, respectively. (O) Expression
of YFP-mDMPK E in DMPK/ myoblasts gives a cytosolic distribution.
Bars, 10 m.
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Golgi apparatus (Fig. 2D to F; also see Fig. S2A to C in the
supplemental material).
In contrast, YFP-mDMPK C in C2C12 cells was completely
colocalized with the mitochondrial marker cytochrome c oxi-
dase but not with the other organellar markers (Fig. 2G to I
and data not shown). We noticed that in some cells weak
YFP-mDMPK C staining also appeared at cytosolic locations.
In these cases, mitochondria often appeared clustered in the
perinuclear region (Fig. 2J) (see below).
To test whether the ER and mitochondrial localization of
mDMPK A and C was uniquely dependent on the sequence
arrangement in their tails and independent of intrinsic kinase
activity, we tagged kinase-dead variants of mDMPK isoforms.
The YFP-mDMPK A(K100A) and C(K100A) distributions at ER
and mitochondria, respectively, were identical to those of their
kinase-active counterparts (Fig. 2K and L).
Next, we tested if partitioning of DMPKs occurred similarly
in myoblast host cells that were rendered completely DMPK
deficient (19). Although these myoblasts lacked the normal
mixture of endogenous DMPK isoforms completely, we ex-
pected them to provide an otherwise fully authentic host en-
vironment, closely mimicking the situation in vivo. When indi-
vidual YFP-tagged mDMPK isoforms A or C were expressed
by adenovirus gene delivery, the typical and selective targeting
to either ER or mitochondria was observed (Fig. 2M and N).
Finally, we also tested other cell types with a zero or very low
level of endogenous DMPK gene expression and hence “ec-
topic” host infrastructure, such as N2A and fibroblast (NIH
3T3) cells, and obtained identical results (data not shown).
Since all these cell types were of mouse origin, we also studied
mDMPKs in human HeLa cells and again found distributions
at exact cognate locations (see below). In all cell types tested,
the third shorter isoform, mDMPK E, adopted a diffuse cyto-
solic distribution (Fig. 2O and data not shown). Based on these
findings, we studied other aspects of DMPK location mainly in
one cell type, choosing N2A as the most amendable cell line
for live cell microscopy, video imaging, and transfection anal-
ysis.
The ER and mitochondria are dynamic structures, which
continuously move and rearrange shape by transport and fu-
sion and fission events (10, 53). To evaluate the role or fate of
mDMPK A and C in these events, we monitored the localiza-
tion of YFP- or CFP-tagged mDMPK isoforms over time in
transiently transfected N2A cells and made parallel compari-
sons to the behavior of otherwise stained organellar markers.
Alterations of the ER network in YFP-mDMPK A-transfected
cells were observed by collecting 2-s-interval time frames (see
Fig. S3A DMPK-A.mov in the supplemental material) and
were similar to alterations observed with a GFP-ER marker
(see Fig. S3B GFP-ER.mov in the supplemental material).
Images of CFP-mDMPK C, collected with a 10-s interval,
reproduced the typical mobility of mitochondria (see Fig. S4
DMPK-C.mov in the supplemental material), as was observed
in colocalization with Rhodamine 123-labeled mitochondria.
Live-cell imaging thus corroborated the association of
mDMPK with ER and mitochondria, each having their own
typical dynamics.
Ultrastructural localization of mDMPK isoforms. Next, we
resolved the localization of mDMPK isoforms at the ultra-
structural level by performing immuno-EM using an anti-GFP
antiserum on YFP-mDMPK-transfected cells. This analysis
showed that mDMPK A was localized exclusively (
95% of
the gold particles) to the cytosolic side of the ER and NE (Fig.
3A). The mitochondria (Fig. 3A) and Golgi complex (not
shown) were unlabeled. High levels of expression of ER-resi-
dent proteins can lead to the formation of stacked ER mem-
brane structures, collectively called organized smooth ER
(OSER), as was recently demonstrated for the TA protein
sequence of cytochrome b5, Sec61, and Sec61 (48). Also in
multiple mDMPK A-overexpressing cells, but never with other
mDMPK isoforms, the formation of comparable parallel or
circular membrane stacks was detected (Fig. 3B). The newly
induced membrane structures, as well as the NE, appeared
dilated and typical for strongly expressing cells (asterisks Fig.
3B and C).
The mDMPK C isoform was specifically associated with
mitochondria. Over 95% of the gold label was found at the
MOM and not at the ER/NE (Fig. 3D and data not shown).
For mDMPK E, no association with particular (membrane)
structures was observed (Fig. 3E). Mouse DMPK E signal
could be observed only in cells fixed with a strong cross-linker
(i.e., glutaraldehyde) in the fixation mixture. Combined, these
data show that isoforms lacking a C-terminal tail are freely
diffusible cytosolic proteins whereas the presence of a tail is
involved in ER or MOM association.
Mouse DMPK A and C are tail-anchored kinases. Cell frac-
tionation followed by chemical extraction procedures was used
to study the mode of mDMPK membrane association. To
assess binding, different buffer and solvent conditions were
used to extract mDMPK from the total membrane fraction. As
shown in Fig. 4, association of mDMPK A and C with mem-
branes, i.e., their presence in the pellet fraction, was resistant
to high salt conditions and alkaline sodium carbonate, indicat-
ing that these proteins are integrated into their target mem-
branes. Only Triton X-100 extraction was able to release
mDMPK A and C from the membrane fraction, shifting it into
the soluble fraction. Previous studies have shown that
mDMPK A, C, and E display doublet bands on immunoblots
associated with autophosphorylation (Fig. 4, asterisks) (15, 54).
In addition, we observed that certain lysis and buffer conditions
induced nonenzymatic clipping of mDMPK with a long C ter-
minus (Fig. 4, brackets; compare mDMPK A and C with
mDMPK E), as occurred here also. Under the conditions used,
the majority of mDMPK E was present in the first supernatant
fraction (S1), confirming that its microscopic classification as a
cytosolic protein was correct.
The observation that mDMPK A and C are strongly associ-
ated with membranes via their C termini places them in a
protein family classified as C-terminally anchored or TA pro-
teins, a recently discovered group of proteins which anchor
preferentially in membranes of the ER or MOM (reference 4
and references therein). This notion prompted us to analyze in
more detail the amino acid composition of tails 1 and 2, with
emphasis on their overall hydrophobicity and positions of
known relevant amino acid residues. Within tail 1, a long
stretch of hydrophobic amino acids is present between posi-
tions 593 and 631. Computer analysis predicted the presence of
a putative transmembrane domain (TMD) between positions
593 and 616 (Fig. 5A). Tail 2 is more hydrophilic, and com-
puter analysis predicted a low probability for the presence of a
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TMD (Fig. 5A). We did identify a stretch of amino acids of
moderate hydrophobicity, excluding any charged amino acids,
between positions 597 and 616. Next, C termini of TA proteins
known to bind membranes of the ER or MOM were compared
with mDMPK tail sequences (Fig. 5B). One evident similarity
between mDMPK tails and ER/MOM targeting sequences of
other TA proteins is that basic residues (i.e., lysine and argi-
nine) are highly prevalent in the regions flanking the 17- to
23-residue long hydrophobic stretches. Since no significant
other similarity emerged from this comparison, these results
suggest that amino acid content as well as amino acid distri-
bution specifies mDMPK anchoring.
A hydrophobic domain in mDMPK tail 1 is responsible for
ER/NE targeting. Previous studies using mutagenesis ap-
proaches have shown that the nature of the TMD and posi-
tioning of flanking lysine and arginine residues determine ER
or MOM localization of TA proteins (5, 18, 21). Therefore, we
examined which particular amino acid residues in tails 1 and 2
were responsible for ER and MOM targeting and whether
basic residues contributed to the targeting specificity of
FIG. 3. Mouse DMPK A and C localize to ER membranes or the MOM. Immuno-EM of YFP-mDMPKs A, C, or E in transiently transfected
N2A cells visualized with an anti-GFP antibody followed by incubation with protein A complexed to 10-nm gold particles is shown (A).
YFP-mDMPK A localized to ER and NE structures. (B and C) Overexpression caused abnormal ER membrane stacks (B) next to dilated ER and
NE structures (B and C, asterisks). (D and E) YFP-mDMPK C localized exclusively to the MOM (D), whereas a cytosolic localization was observed
for YFP-mDMPK E (E). M, mitochondrion; N, nucleus. Bars, 100 nm.
FIG. 4. Mouse DMPK A and C are tail-anchored proteins. West-
ern blots of pellet (P) and supernatant (S1 and S2) fractions of N2A
cells transfected with mDMPK A, C, or E after phosphate-buffered
saline (PBS), high-salt, alkaline Na2CO3, or Triton X-100 extraction of
100,000 	 g pellets. N2A cells were grown, transfected, and fraction-
ated into supernatant and pellet fractions before extraction as de-
scribed in Materials and Methods. DMPK was visualized with an
anti-DMPK antibody. inp., input; S1/S2 and P, supernatant and pellet
fractions after 100,000 	 g centrifugation. Asterisks mark doublet
DMPK signals, and brackets indicate C-terminally truncated mDMPK
products as a result of nonenzymatic breakdown (see the text).
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mDMPK. Deletion mutants of mDMPK A and C or the sep-
arate tails were fused to YFP, and the subcellular localization
of the chimeric proteins was examined during transient expres-
sion in N2A cells (Fig. 6A). Proper expression of YFP fusions
was assessed via immunoblotting (see Fig. S1 in the supple-
mental material). Tail 1 alone was sufficient to target YFP,
normally mainly a cytosolic/nuclear protein (Fig. 6B), to the
ER (Fig. 6C) and the NE (see Fig. S2D to F in the supple-
mental material). Analysis of additional mutants showed that
all information was present in amino acids 579 to 631 (Fig. 6D
and E; see Fig. S2G to I in the supplemental material). This
confirmed that, as predicted from comparison with other TA
proteins, the ER targeting signal is contained within the ulti-
mate C-terminal part of tail 1. Involvement of basic residues
was investigated by further truncating tail 1 to amino acids 585
to 631, thereby removing R581 and R584 but leaving R591 in
place. Fusion protein YFP-mDMPK A(585–631) still localized to
ER networks (Fig. 6F) as well as to the NE (see Fig. S2J to L
in the supplemental material), indicating that R581 and R584
are not required for ER targeting. Also, an additional R591A
mutation did not affect the ER/NE association (Fig. 6G; see
Fig. S2M to O in the supplemental material). This supports the
idea that positively charged amino acids are not required for
proper ER targeting of tail 1. Hence, the ER targeting signal
for mDMPK A is confined within the ultimate 40 amino acids
of tail 1, encompassing a putative TMD.
Mitochondrial targeting by mDMPK tail 2 requires basic
residues flanking a putative TMD and presence of the coiled-
coil domain. We also examined requirements for mDMPK C
anchoring in more detail. Unlike for mDMPK A, just the tail
region of mDMPK C appeared insufficient for targeting YFP
to mitochondria, since a YFP-mDMPK C(536–632) fusion pro-
tein was found in the cytosol and to some extent also in the
nucleus (Fig. 6H). When the coiled-coil domain was included,
as in fusion protein YFP-mDMPK C(421–632), mitochondrial
localization was nearly completely restored (Fig. 6I). To de-
termine whether a leucine zipper motif in the mDMPK N
terminus participated in the binding of DMPK C to mitochon-
dria, this domain was deleted. Its absence did not affect normal
mitochondrial distribution (Fig. 6J). Although this does not
necessarily exclude any targeting role for the motif, it makes a
direct role in mitochondrial targeting unlikely. In contrast, the
C-terminal 45-amino-acid domain plays a dominant role, since
removal of the polypeptide stretch between positions 588 and
632 resulted in a cytosolic localization (Fig. 6K). Thus, the
targeting signal of mDMPK C must be contained within the
C-terminal 45 amino acids, similar to the situation in
mDMPK A. When R624 positioned at the C-terminal side of
the putative TMD in tail 2 was mutated to alanine, a small but
significant fraction of the YFP-tagged protein shifted to a
location in the cytosol, and the mitochondria to which the
majority of protein still bound appeared rounded and frag-
mented (Fig. 6L). This suggests that R624 plays an important
role in determining targeting specificity for the MOM (see also
below). Finally, introduction of mutations R588A and R589A
completely abolished mitochondrial localization (Fig. 6M), in-
dicating that positively charged residues preceding the TMD
are important in the targeting signal of tail 2. Taken together,
our results demonstrate that MOM targeting by mDMPK tail
2 requires the presence of the coiled-coil domain as well as
critical basic residues flanking the putative TMD in the 45-
amino-acid tail domain.
The human DMPK A orthologue associates with mitochon-
dria instead of the ER and causes mitochondrial clustering.
Although the amino acid sequences of DMPK isoforms are
highly homologous between humans and mice (15), we found
it conspicuous that the percent sequence identity and similarity
for the C termini fell far below the overall values for the whole
tail region (see Table S1 in the supplemental material). Be-
tween the two species, strong differences exist mainly in the
presence and arrangement of essential basic residues, in par-
ticular for tail 1. The positioning of basic residues in the human
sequence suggested that hDMPK A would localize to mito-
chondria and not to the ER, like mDMPK A (see Fig. S5 in the
FIG. 5. Mouse DMPK tail 1 and 2 anchors have different sequence arrangements and hydrophobicity profiles. (A) Hydrophobicity plots of
mDMPK tails 1 and 2. The average hydrophobicity of the assigned TMD (25) is indicated. (B) Comparison of DMPK tail 1 and 2 sequences with
ER and MOM targeting sequences of known tail-anchored proteins. Putative TMDs are boxed, and basic residues are shown in bold. Amino acid
numbering for mouse and human DMPK isoforms is indicated (see also Fig. 1A).
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supplemental material). To test this hypothesis, we compared
the localization of YFP-hDMPK A and C with that of their
mouse orthologues (Fig. 7). In our analyses, we included HeLa
cells in order to exclude cross-species effects caused by mem-
brane composition in combination with features in the DMPK
sequences. As anticipated, we observed that not only hDMPK
C but now also hDMPK A localized to mitochondria in both
N2A and HeLa cells (Fig. 7). Again, the subcellular localiza-
tion of mDMPK A and C was independent of the species origin
of the recipient cell line (data not shown). Immuno-EM con-
firmed that both hDMPK isoforms were indeed localized ex-
clusively (
95% of the gold label) at the MOM (Fig. 8).
Even more strikingly, we observed a dramatic effect of
hDMPK A expression on the morphology and distribution of
mitochondria throughout the cytoplasm. In the majority of
YFP-hDMPK A-transfected cells, mitochondrial clustering oc-
curred in the perinuclear region (Fig. 7A to C and G to I and
Fig. 9). Importantly, this was found exclusively for hDMPK
A-decorated mitochondria and was also observed in C2C12
myoblasts (Fig. 7I; see Fig. S6 in the supplemental material).
Clustering of mitochondria was not seen in cells in which the
mDMPK A isoform was expressed, although here aggregated
ER structures were frequently observed (Fig. 3B and 9). More-
over, comparison of cells with high and low hDMPK A expres-
sion revealed that mitochondrial aggregation occurred seem-
ingly independently of the expression level (data not shown).
These observations suggest that the mode of hDMPK A bind-
ing to the target organelle rather than overexpression per se is
involved in the organellar redistribution. Further analyses also
revealed that many transiently transfected cells showed exten-
sive blebbing and a high incidence of cell death. This could be
a consequence of the anomalous distribution of mitochondria,
associated with as yet unknown effects on cell physiology. It is
of note here that relatively mild mitochondrial clustering was
observed in cells expressing human or mouse DMPK C (Fig.
7D to F and J to L and Fig. 9), but increased cell death was
never observed in these cells. Taken together, these data show
that DMPK isoforms have a localized function and that mito-
chondrial isoforms can differentially influence mitochondrial
characteristics.
DISCUSSION
In the present study, we analyzed parameters involved in the
subcellular distribution of protein products of DMPK, the gene
mutated in DM1 (16). We demonstrate that distinct mouse
DMPK splice isoforms specifically associate with either the ER
membrane or the MOM, guided by unique sequence informa-
tion in their C-terminal tail. Human DMPK forms show no
divergence in localization and target to mitochondria only. To
our knowledge, DMPK is the first protein kinase that can be
classified into the recently established group of TA proteins
(reference 4 and references therein).
DMPK is a tail-anchored serine/threonine protein kinase.
TA proteins constitute a group of proteins that specifically
insert into intracellular membranes, using a single membrane-
spanning region located close to the COOH terminus (refer-
ence 4 and references therein). Similar to what was found for
FIG. 7. Human DMPK A and C localize to mitochondria and alter
mitochondrial distribution. Confocal fluorescence microscopy analysis
of YFP-hDMPK A and C in transiently transfected N2A (A to F) and
HeLa (G to L) cells. YFP-hDMPK A localized at mitochondria,
stained by an anti-cytochrome c oxidase marker, which accumulated in
the nuclear periphery. YFP-hDMPK C also localized to mitochondria
(D to F and J to L) but did not show the accumulation near the nucleus
as observed for hDMPK A (B and H). Note that mitochondria devoid
of hDMPK A remain unclustered (H). Bars, 10 m.
FIG. 6. Involvement of basic residues in tail anchors in localization of mDMPK A and C. (A) Schematic representation of mDMPK A and C
deletion constructs and their subcellular localization: ER, NE (nuclear envelope), Cyto (cytosol), Nucl (nucleus), Mito (mitochondrial). (B to M)
Confocal images of fluorescent YFP-tagged DMPK A or C deletion mutants in N2A cells. Transfected N2A cells expressing unmodified YFP were
used as the control (B). ER localization of mDMPK A deletion constructs was found for tail 1 alone (YFP-mDMPK A(536–631)) (C) and
YFP-mDMPK A(579–631) (E), YFP-mDMPK A(585–631) (F), and YFP-mDMPK A(585–631/R591A) (G), but not for YFP-mDMPK A(536–585) (D). Tail
2 of mDMPK C alone did not target to mitochondria (YFP-mDMPK C(536–632)) (H), whereas YFP-mDMPK C(421–632) (I) and YFP-mDMPK
C(64–632) (J) yielded a mitochondrial localization. The C-terminal 45 amino acids are essential for mitochondrial localization (YFP-mDMPK
C(1–587) (K) and also the basic residues therein, since expression of YFP-mDMPK C(R624A) results in rounded and fragmented mitochondria
(L) whereas YFP-mDMPK C(R588A/R589A) localizes to the cytosol (M). Bars, 10 m.
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the location preference of most tail-anchored proteins (4, 55),
mDMPK localization is confined to either membranes of the
ER or NE (for tail 1) or to the MOM (for tail 2). Since no
appreciable colocalization with Golgi markers or the plasma
membrane was observed for mDMPK A, we conclude that the
protein, after translation and insertion into the ER membrane,
is not further sorted into the vesicular transport route. How
this is regulated, via lipids or through active retention, is at
present unknown.
Anchoring of mDMPK A and C into their target membranes
must be strong, since they cannot be liberated by high-salt or
alkaline sodium carbonate treatment. Since the membrane an-
chors of mDMPK A and C are positioned within the last 40
C-terminal amino acids, we consider it most likely that mem-
brane insertion occurs posttranslationally in an Nout-Cin orien-
tation. Exactly how mDMPK is anchored in the membrane is
not clear, however, and hypothetical models in which mDMPK
tails span the membrane or attach to the lipid bilayer are still
open (Fig. 10, modes I and II). Further mechanistic studies are
therefore required to decide between possible modes of mem-
brane association.
Structural features of ER- and MOM-targeting signals of
DMPK isoforms. Little is known about the molecular machin-
ery and steps involved in partitioning of TA proteins into the
ER or MOM, except that conventional import pathways do not
seem to apply (3, 4). A specific role for the signal recognition
particle for targeting of TA proteins to the ER was reported
(1), but detailed insight in the mechanism of membrane inser-
tion is currently lacking. Data from various studies suggest that
shared structural elements in C termini reflect the only critical
features implicated in membrane selectivity. To discriminate
between various mechanistic hypotheses, we started here by
making a comparison between elements in the tail sequences
of DMPK A and C and other members of the group of TA
proteins. Length and hydrophobicity of the TMD, together
with flanking basic amino acids, have been proposed as the
most crucial determinants of membrane selectivity (5, 18, 21,
FIG. 8. Human DMPK A and C both localize to the MOM. Immuno-EM of YFP-hDMPK A (A) and C (B) in transfected N2A cells show
localization of human DMPK isoforms to the MOM. Procedures for transfection, immunogold labeling, and imaging are as described in the legend
to Fig. 3 and in Materials and Methods. M, mitochondrion. Bars, 100 nm.
FIG. 9. Human DMPK A promotes mitochondrial clustering at
perinuclear sites. The fraction of N2A and HeLa cells containing
clustered mitochondria was determined after transient transfection
with vectors encoding mouse or human DMPK isoforms A and C.
Mitochondria were regarded as clustered when virtually all cyto-
chrome c oxidase-positive mitochondria aggregated near the nucleus.
The extent of clustering induced by hDMPK A in N2A cells is probably
underestimated because many transfected cells showed an apoptosis-
like appearance and therefore were excluded from the assay (asterisk).
A minimum of 100 cells was analyzed for each cell type and each
DMPK expression vector. Subcellular localization of DMPK isoforms
is indicated.
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24). Positively charged amino acids preceding the TMD may be
essential for ER localization, as demonstrated for VAMP-1A,
VAMP-2, and VAMP-8 (22). We observed here, however, that
an mDMPK A mutant lacking all three basic residues preced-
ing the TMD remained associated with ER and NE mem-
branes. We can exclude compensatory replacement effects of
amino acids placed immediately upstream of the TMD in the
tail since all basic residues derived from the C-terminus of YFP
and a short stretch of amino acids specified by the multiple-
cloning site in the vector were removed (see the supplemental
information). Previous reports showed that a reduction in the
overall positive charge C-terminally of the TMD results in
higher affinity for ER membranes (18, 24). The fact that amino
acids following the TMD in the mDMPK A tail are all neutral
is consistent with this observation and may determine binding
strength. Taking these data together, we conclude that it is the
strong hydrophobic character of the mDMPK A TMD (aver-
age hydrophobicity of 2.1) that constitutes the ER and NE
targeting signal. Our findings are compatible with other studies
showing that artificially engineered stretches of hydrophobic
amino acids of different lengths can be sufficient for ER tar-
geting (56, 58).
Clearly, for the MOM targeting of mDMPK C, more elab-
orate structural information is required, as can be inferred
from the cytosolic localization of YFP-mDMPK C(1–587) and
YFP-mDMPK C(536–632). Although the coiled-coil domain by
itself confers no targeting properties, as is evident from the
cytosolic localization of mDMPK E, the amino acid informa-
tion in this domain appeared a critical component for correct
MOM association of mDMPK C. This could indicate that,
apart from providing the appropriate sequence context, the
coiled-coil domain could also play a role in protein-protein
interactions that determine the specificity and strength of
MOM binding (Fig. 10, hypothetical binding modes III and
IV). Alternatively, close proximity of coil segments could exert
intramolecular effects on the tail conformation necessary for
determining MOM anchoring specificity. Whether we can draw
any structure-function analogy to proteins with a similar ar-
rangement of membrane-proximal coils and membrane-in-
serted domains, like the SNARE proteins, remains a question
for future study (32). Previous work indicated that basic resi-
dues flanking a TMD dictate MOM targeting of TA proteins
(4, 21). Consistent with this observation, we report here that
mutations R588A and R589A render mDMPK C a cytosolic
protein. Remarkably, reducing the basic amino acid content of
the very C-terminal end of the tail, by mutating Arg at position
624 to Ala, did not abolish the specificity of the MOM signal.
This observation and the finding that its C-terminal end has a
net negative charge gives mDMPK C a unique position in the
group of MOM anchored proteins.
Interestingly, the sequence arrangements that differ between
human and mouse DMPK A tails confer differential properties
to the protein, in that hDMPK A is targeted to the MOM
whereas mDMPK A associates with the ER. This finding was
unanticipated, since there is a remarkable conservation of gene
structure and alternative splice sites between the two DMPK
genes (15). Perhaps preference for MOM anchoring of
hDMPK A is determined by the distinct positioning of basic
residues within its tail. Neutral amino acids in the C-terminal
stretch of mDMPK A are replaced by basic residues in
hDMPK A (see Fig. S5 in the supplement material). More
probably, the Arg at position 600 in the human protein breaks
up the hydrophobic stretch that was identified as the minimal
ER-targeting signal in the mouse form. As a consequence, the
resulting tail has a TMD with a lower hydrophobicity, probably
too low to promote ER binding. Indeed, an R600A mutation in
the human tail 1 sequence resulted in an ER-localized protein,
but deletion of the final 10 C-terminal residues, including 3
arginines, did not alter mitochondrial localization (data not
shown). Variation in the guidance motifs in tail anchors may
provide an adaptive mechanism for matching intracellular lo-
cation to function during evolution. On the one hand, we
FIG. 10. Hypothetical modes of membrane association of DMPK isoforms. A schematic representation of the putative association of DMPK
isoforms with their target membrane is shown. C-terminal DMPK anchors can either pass the membrane entirely (mode I) or give close surface
binding to the outer leaflet of the lipid bilayer (mode II). A requirement of the coiled-coil domain for proper MOM localization of mDMPK C
suggests that either heterologous protein interactions may stabilize mDMPK localization at the membrane (mode III) or multimerization of DMPK
via the coiled-coil domain may promote binding specificity and/or strength (mode IV). Possible intramolecular effects of proximity of the coiled-coil
segment on folding of the hydrophobic domain can also be envisaged but are not included in the figure.
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should therefore consider the possibility that the difference in
location preference rendered the functions of mouse and hu-
man DMPK. A orthologues completely divergent. On the
other hand, it is conceivable that for proper function DMPK
needs to be positioned close to sites of ER-MOM contact,
which can be specified by association with either the ER or
MOM side of the membranous interphase. No such specula-
tion about an evolutionary shift in function for the DMPK C
isoforms is needed, since both DMPK C isoforms show an
identical distribution at the MOM in both human and mouse
cells.
Under conditions of high expression, human and mouse
DMPK C both adapted a cytosolic localization. This suggests
that the MOM interaction of DMPK C can become saturated,
as was also shown for VAMP-1B (27). It is important to note
here that such an effect was never observed for hDMPK A.
Our interpretation of this finding is that, besides the stronger
hydrophobicity of the TMD, the net positive charge of 3 of
the C-terminal region of the hDMPK A tail, as opposed to the
net negative charge found in human and mouse DMPK C,
contributes to its more efficient anchoring into the MOM.
Species differences in lipid composition of the MOM may
influence the requirements of the targeting signal, as shown for
the TOM5 protein in yeast and mammalian cells (18). Our
observation that the specificity of location is retained between
human and mouse DMPK isoforms in cultured cells of human
and mouse origin implies, however, that species effects of
membrane lipid composition on the location of tail-anchored
proteins are of no or only minor concern when compared
between mammals.
Perinuclear clustering of mitochondria and OSER forma-
tion by DMPK A. An interesting and important difference
between DMPK isoforms from mice and humans was that
hDMPK A preferentially clusters mitochondria near nuclei
while mDMPK A can form OSER structures. Perinuclear clus-
tering and aggregation of mitochondria has also been observed
in cultured cells when expressing proteins like mitofusin 1 and
2, as well as with hFIS1 (42, 44, 59), OMP25 (36), or OPA1
(46). Except for OMP25, these proteins are involved in fusion
or fission of the mitochondrial membrane, contain a coiled-coil
domain, and have targeting properties in common with TA
proteins (42, 43, 59). One possible explanation for the ob-
served aggregation effects could be that cytosolic exposure of
the coiled-coil domain of hDMPK A induces complex forma-
tion and brings together opposing mitochondrial membranes,
similar to what was reported recently (23). Interactions be-
tween coiled-coil regions contribute to DMPK multimerization
(8; R. E. M. A. van Herpen et al., unpublished data), and it is
therefore likely that these segments just upstream of the tails
play an active role in the clustering behavior. We can virtually
rule out low-affinity dimer-binding effects of the YFP-tag since
this moiety was present in both constructs but mitochondrial
aggregation ability differed profoundly between hDMPK C
and A isoforms (compare Fig. 7K and H). To explain why the
effect was much weaker with DMPK C, we will need more
information about the topology of membrane insertion for
each of the DMPK variants. Current evidence also indicates
that low-affinity protein interactions at the cytosolic side of the
ER membrane are sufficient to promote OSER formation (48).
Coiled-coil regions of mDMPK A may therefore have contrib-
uted to the effects seen at the ER membrane as well.
Perinuclear clustering of mitochondria can play diverse
roles, including the initiation of apoptosis (50) or local modu-
lation of intracellular Ca2 transients, as observed in parotid
acinar cells (7). Fission and fusion behavior and movement of
mitochondria are dependent on the integrity of the cytoskel-
etal network, and we know that DMPK may play a role in
actomyosin dynamics by controlling myosin phosphatase activ-
ity via MYPT1 phosphorylation (2, 35, 54). Thus, a functional
link between DMPK activity on the cytosolic face of the MOM
and interaction with the actin cytoskeleton could well affect
mitochondrial distribution. Whether similar associations also
could play a role in OSER formation is not known.
Results presented here, combined with preliminary findings
in a previous study (54), now suggest a model where distinct
locations by insertion into ER or MOM membranes via unique
tail anchors determine DMPK’s functional selectivity of activ-
ity. Organelles themselves appear to serve as organizing plat-
forms for DMPK function and its subsequent role in cell
signaling. Elucidation of possible reciprocal effects of multim-
erization and kinase activity on organellar membrane dynamics
ultimately will be essential for understanding the function of
DMPK. Parallel study of DMPK isoforms from different spe-
cies may be helpful in these studies.
Finally, it is important to note that our findings were
confirmed by results obtained with various types of cells,
including skeletal muscle-derived myoblasts which, before
and after fusion into myotubes, provide the normal host
environment for DMPK A and C. Strict control of isoform
ratios of C-tailed DMPKs and their levels and location may
very well be important for the well-being and viability of
muscle cells and other cell types in which the DMPK gene is
expressed. In view of the cytopathological effects reported
here, this may be especially true for the human DMPK A
and C gene products. Just recently, our group has published
results showing that cumulative distress of overexpression of
hDMPK in a transgenic-mouse model translates into in-
creased muscle workload intolerance, hypertrophic cardio-
myopathy with dysrhythmia, myotonic myopathy, and hypo-
tension (37). Further research is thus warranted to see if an
imbalance in the mitochondrial targeting and the associated
aggregation behavior demonstrated here could have con-
tributed to these DM1-like traits.
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